China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response: The Lancet
Source: Xinhua Published: 2020/7/20 22:17:38
Vaccine file photo:Xinhua
A phase 2 trial of a COVID-19 vaccine candidate conducted in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
Posted in: SOCIETY